|Home | About | Journals | Submit | Contact Us | Français|
The objective of the present study was to investigate the antioxidant status and the extent of oxidative DNA damage in lymphocytes and their relation with essential hypertension (EHT). A total of 100 South Indian subjects aged 30–65 were included for the study. Of these 50 were normotensive controls (group-1) with blood pressure ≥120/80 mm Hg, 50 were newly diagnosed (group-2) and were not on any antihypertensive drugs, but had systolic blood pressure ranging between 140 and 160 mmHg and diastolic blood pressure 95–100 mmHg and 50 newly diagnosed essential hypertensive patients underwent drug therapy for 1 year was considered as group-3. Enzymatic and non-enzymatic antioxidants significantly decreased and lymphocyte DNA damage was significantly increased in newly diagnosed hypertensive patients compared with control group. The major decrease in DNA damage and significant improvement in enzymatic and non-enzymatic antioxidants were observed after 1 year of antihypertensive therapy in treated group compared with newly diagnosed hypertensive patients. Total antioxidant status and lymphocyte DNA damage showed a strong negative correlation in all the three groups. Essential hypertension associated with oxidative stress which in turn causes genotoxic susceptibility to variety of disease including cancer. In the absence of DNA repair process and DNA checkpoint mechanisms, the genomic integrity is susceptible to extensive damage. In our study, increased oxidative DNA damage and decreased antioxidant levels were frequently observed in the newly diagnosed essential hypertensive patients, suggesting that oxidative stress is important in the pathogenesis of EHT. Therefore, the present study has additional clinical implication. Further investigations with large number of patients along with antioxidant supplement are highly warranted.
Hypertension is a major health problem in developed as well as developing countries with a common end result of elevated blood pressure (BP). Hypertension is present in 60–70 % of the population over 60 years of age and may result in cardiovascular complication such as stroke, coronary heart disease (CHD), and heart failure.
Hypertension (HT) is considered as a state of oxidative stress that can contribute to the development of atherosclerosis and other HT-induced organ damage. Lymphocyte DNA damage is caused by various factors including oxidative stress mainly.
Essential hypertension (EHT) or “pre-hypertensive” refers to the high blood pressure with no identifiable causes it can be diagnosed when the systolic pressure (SBP) greater than 140 mmHg and/or diastolic pressure (DBP) of 80–90 mmHg at 3 random checks and need medical monitoring and lifestyle changes . EHT is a common trait of multifactorial determination, imparting an increased risk of cardiovascular, cerebrovascular and renal disease. Several lines of evidence suggest that patients with essential hypertension have impaired balance between oxidant and antioxidant. However the mechanism underlying these abnormalities and its effect on DNA level remains unclear.
It has been proposed that release of oxygen free radicals (OFR) would be stimulated by acute hypertension and this increase in OFR might mediate the vascular damage, which can be seen in hypertensive subjects. OFR are highly reactive and can damage cellular membranes through lipid peroxidation [2, 3]. Recent experimental evidence suggests that oxidative stress plays an important role in the development of high BP in some animal model .
The alkaline comet assay has been extensively used for human biomonitoring studies. Lymphocytes are the preferred cell type as they are an internationally accepted indicator tissue to asses the consequence of human exposure to genotoxic hazard [5, 6].
Comet assay is a simple, sensitive, rapid and non-invasive technique for the assessment of DNA damage in an individual cell. Lymphocyte DNA damage is caused by multiple factors including, oxidative stress mainly [7, 8] and the other causes such as coronary artery diseases  and inflammation [10–12]. It has been suggested that oxidative stress and the generation of reactive oxygen species may play an important role in the induction of DNA damage in atherosclerosis .
During therapy the entire patients received different antihypertensive drug with various combination. In this group we are not looking for single drug and its effect. On the whole, the complete status of antihypertensive drug effect over oxidative stress in essential hypertensive patients was seen. The following drugs was administered in Dr. K. M. Cherian Heart Foundation, Natrilix SR (diuretics), Telmisartan (Angiotensin II receptor antagonist), Amlodipine and Nifedipine (calcium channel blocker), Doxazosin (alpha blocker), Prolomet XL (beta blocker), Carvedilol (both alpha and beta blocker) and Captopril (ACE inhibitor).
The purpose of the present study was to explore the antioxidants activities and oxidative DNA damage in essential hypertensive patients before and after antihypertensive drug therapy and to examine the possible relationship between the oxidative stress and blood pressure levels.
Controls were fifty normotensive healthy subjects without any family history of hypertension (group-1). Fifty essential hypertensive patients age range from 30 to 65 years visiting Dr.K.M.Cherian Heart Foundation, Chennai were selected for the study. Hypertension was diagnosed when the systolic and diastolic pressure read 140 and 90 mmHg respectively at 3 random checks. 50 newly diagnosed essential hypertensive patients without any previous history of antihypertensive medication (group-2) and 50 newly diagnosed essential hypertensive patients underwent drug therapy for 1 year was considered as group-3.
All the participants underwent a detailed clinical examination and their BP and ECG were recorded. A fully informed consent was obtained from these subjects prior to participation in the study. The study was approved by both research and ethics committee of our institute.
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee.
Subjects with secondary hypertension, past history of stroke, coronary artery disease (CAD), myocardial infarction, and peripheral vascular disease with evidence of tissue injury or loss, renal diseases, diabetes mellitus, after infections, smokers, alcoholic and who with vitamin supplement, known to cause changes in antioxidant and lipid status, were excluded from the study.
5 ml of peripheral venous blood samples were drawn from all the subjects in the fasting state and placed in heparinized tubes. 1 ml of heparinized blood was pipetted into another tube immediately for the analysis of lymphocyte DNA damage by comet assay. The remaining blood was centrifuged at 3000 rpm × 10 min for plasma separation. Plasma samples were used for the analysis of TAS, vitamin C, vitamin E, protein thiols, Catalase, fasting blood glucose and lipid profile. The Hemolysate samples were used for the analysis of Reduced glutathione, Superoxide dismutase, Glutathione peroxidase, Glutathione-s-transferase, and Malondialdeyde.
Plasma triglyceride, total cholesterol, LDL, HDL and fasting glucose concentration were measured with an auto analyzer (Randox Daytona, clinical biochemistry analyzer) by using commercial kits.
Non-enzymatic antioxidant such as GSH, vitamin C, vitamin E, protein thiols and TAS were assayed by the method of Beutlar et al. (1963), Omaye et al. (1979), Desai (1984), Sedlak and Lindsay (1968) and Ferric reducing antioxidant power (FRAP) respectively [14–18].
Enzymatic antioxidant such as SOD, CAT, GPX and GST were assayed by the method of Winterbourn et al. (1975), Aebi (1984), Flohe and Gunzler (1984) and Coombes B and Stakelum GS (1961) respectively [19–22].
Lipid peroxidation product, MDA was determined by Ohkawa  et al. (1979).
Lymphocyte DNA damage by comet assay was determined by the method of Singh  et al.
The endogenous lymphocytes DNA damage was analyzed by alkaline comet assay by the method of Singh et al. with minor modifications.
Lymphocyte isolation for the comet assay was performed by using the Histopaque 1077 (Sigma). An amount of 1 ml heparinized blood was carefully layered over 1 mL Histopaque and centrifuged for 35 min at 500×g at 25 °C. The interface band containing lymphocyte was washed with phosphate buffer saline (PBS) and then collected by 15 min centrifugation at 400×g. The resulting pellets were resuspended in PBS to obtain 20,000 cells in 10 μL.
Membrane integrity of lymphocyte cells was assessed by using Trypan Blue exclusion method.
Ten micro liter of fresh lymphocyte cell suspension (around 20,000 cells) was mixed with 80 μL of 0.7 % low melting point agarose (LMA) (Sigma) in PBS at 37 °C. Subsequently, 80 μL of this mixture was layered onto slides that had previously been coated with 1.0 % hot normal melting agarose (NMA), covered with a cover slip at 4 °C for at least 5 min to allow the agarose to solidify.
After removing the cover-slips, the slides were submersed in freshly prepared cold (4 °C) lysing solution (2.5 M NaCl, 100 mM EDTA-2Na; 10 mM Tris–HCl, pH 10–10.5; 1 % Triton X-100 and 10 % DMSO added just before use) for at least 1 h. Slides were then immersed in freshly prepared alkaline electrophoresis buffer (0.3 mol/L NaOH and 1 mmol/L Na2ETDA, pH > 13) at 4 °C for unwinding (30 min) and then electrophoresis was performed (400 mA/24 V, 25 min).
All of the above steps were conducted under red light or dim light in order to prevent additional DNA damage. After electrophoresis, the slides were stained with ethidium bromide (2 μ/mL in distilled water; 80 μL/slide), covered with a cover slip and analyzed by using a fluorescence microscope (Olympus).
The images of 100 randomly chosen nuclei (50 Cells from each of two replicate slides) were analyzed visually by manual scoring . As shown in Fig. Fig.11 each image was classified according to the intensity of the fluorescence in the comet tail and was given a value of either of 0, 1, 2, 3 or 4 (from undamaged class 0 to maximally damaged class 4), so that the total scores of slide could be between 0 and 400 Arbitrary Units (AU). All procedures were completed and the extent of DNA damage was detected by a single observer.
Total antioxidant status of plasma was determined by ferric reducing antioxidant power assay [26, 27], whereby at low pH, reduction of a ferric tripyridyl triazine (Fe3+-TPTZ) complex to a ferrous form, which had an intense blue color, that can be monitored by measuring the absorbance at 593 nm using spectrophotometer. It was directly related to the combined or total reducing power of the electron donating antioxidants present in the reaction mixture. The results were expressed as micro mole per liter.
Results are expressed as mean ± S.D or frequency expressed as a percent, categorical variables were compared by using χ2-test. We assessed normality of all study variables through Kolmogorov–Smirnov one sample test (K-S test). Comparison among multiple groups was performed by one-way analysis of variance (ANOVA) with LSD post hoc test for continuous variables. Correlation of lymphocyte DNA damage with total antioxidant status was assessed by Pearson correlation coefficient. Values of probability less than 0.05 was considered statistically significant. The statistical analysis was performed with SPSS 12 for windows.
The base line characteristics and lipid profile of EHT patients and control groups are summarized in Table 1. Total cholesterol, TAG, LDL (p < 0.05) was significantly increased in EHT patients when compared with controls, whereas HDL (p < 0.05) was significantly decreased in EHT patients when compared with control group.
Reduced glutathione, vitamin C, protein thiols and TAS was significantly decreased in newly diagnosed EHT patients when compared with control and EHT-during therapy group (p < 0.05). After 1 year of treatment there was significant increase in non-enzymatic antioxidants when compared with EHT newly diagnosed group (p < 0.05). Vitamin E does not show significant change between EHT-Newly diagnosed and during therapy (Table 2).
As shown in Table 3, Enzymatic antioxidants like SOD, Catalase, GPx, GST was significantly decreased in newly diagnosed EHT patients when compared with control and EHT-during therapy group (p < 0.05). After 1 year of treatment there was significant increase in enzymatic antioxidants when compared with EHT newly diagnosed group (p < 0.05).
Mean MDA and lymphocyte DNA damage of EHT patient group was found at high level compared with control group (p < 0.05) and Mean lymphocyte DNA damage of EHT-Newly diagnosed group was found significantly high compared with EHT patient-During therapy (p < 0.05, Table 4).
Mean total antioxidant status and lymphocyte DNA damage was illustrated in Figs. 2 and and3.3. Lymphocyte DNA damage was negatively correlated with TAS and it is highly significant (p < 0.0001). The correlation of lymphocyte DNA damage with TAS of all the three groups was illustrated in Fig. 4.
To the best of our knowledge, the present study is the first report in South Indian Population to evaluate the association between lymphocyte DNA damage and antioxidants in both newly diagnosed and during drug therapy for 1 year. Our findings showed that oxidative DNA damage occurs in essential hypertensive patients more than in normal blood pressure subjects and that the oxidative DNA damage is significantly reduced by the administration of antihypertensive drugs for the period of 1 year.
We used lymphocytes as a cell line for detecting oxidative DNA damage due to the fact that it is readily available and widely used as a sentinel cell type to provide early warning signals for adverse effects, an attempt was made to see whether oxidative stress in essential hypertensive patients subsides after undergoing antihypertensive therapy for the period of 1 year.
An explanation for the observed reduction in antioxidant status among hypertensive patients could be due to the presence of increased free radicals and decreased antioxidants as it utilized for neutralizing free radicals. Free radical triggers the depletion of plasma antioxidants and increase lipid peroxidation. The reduction in antioxidant status and increased production of MDA in the hypertensive patients confirms the presence of oxidative stress. Possible mechanism of ROS production in hypertension is due to increased membrane peroxidation leads to vascular damage in hypertensive subjects which is a suggestive feature of oxidative stress in hypertension. Our results are also consistent with the previous study [28–32].
Oxidative stress due to over production of ROS outstripping antioxidant defense mechanism has been implicated in many pathophysiological conditions that affect the cardiovascular system, such as hypercholesterolemia, diabetes and hypertension [33–37]. Decreased antioxidant capacity  and increased ROS release  were shown to be associated with essential hypertension [40, 41].
Our preliminary observations, provides evidence that oxidative DNA damage was associated with depletion of extra cellular antioxidants in essential hypertensive patients. Also TAS assay reflects a general antioxidant capacity of plasma to which protein thiols mainly contribute.
Increased oxidative status may initiate lipid peroxidation in cell membranes, damage membrane proteins or cause DNA fragmentation. These processes may result in a loss of heart contractile function and lead to severe myocardial cell damage . Honda et al.  reported that reduced activities of the antioxidant enzymes were associated with increased levels of oxidative DNA damage. However in present study, the TAS levels, which provide a measure of total defenses against ROS were found at low level in hypertensive patients.
Our study clearly shows that, increased oxidative DNA damage and decreased antioxidant levels were frequently observed in the newly diagnosed essential hypertensive patients, suggesting that oxidative stress is important in the pathogenesis of essential hypertension. Consequently, prevention of DNA damage may be inadequate in hypertensive patients with particularly newly diagnosed EH patients. Furthermore, in this group, presence of low level of TAS and high level of lymphocyte DNA damage may be plausible.
Essential hypertension may leads to severe troublesome problem in humans. Therefore, we should focus on the prevention of development of essential hypertension as well as on the reduction of the complication of hypertension. Oxidative damage is closely related to the development and complication of essential hypertension.
Furthermore, Oxidative DNA damage also should be importantly considered because it may change genes and result in problems for offspring of those with DNA damage. Doctors do not know in their daily practice who might have more serious oxidative damage, especially DNA damage, among hypertensive patients. Therefore, we need accurate and sensitive method like COMET assay for oxidative DNA damage so that we can use the appropriate drug for antihypertensive medications, for hypertensive patients who have more DNA damage.
In conclusion, the finding of increased lymphocyte DNA damage of EHT patients indicates the potential genetic hazards posed by oxidative stress and emphasizes that ROS occurs more in newly diagnosed essential hypertensive patients than in persons with normal blood pressure. Thus the study shows that essential hypertension is associated with increased oxidative stress and reduced antioxidant status. Adequate control of blood pressure with antihypertensive therapy decreases oxidative DNA damage and improves the antioxidant status in essential hypertensive patients.
The author declares no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee. The study was approved by both research and ethics committee of our institute.
A fully informed consent was obtained from all the subjects prior to participation in the study.